|
|
| Research article summary (published 30 Oct 2008): |
Zotepine-induced spontaneous ejaculation.
Full Abstract
A man with schizophrenia received regular haloperidol ester therapy, but his psychotic symptoms were not mitigated. A combination of zotepine and haloperidol was then used to relieve the psychotic symptoms. However, the patient developed spontaneous ejaculations, which occurred many times a day while undergoing haloperidol and zotepine therapy. These events were not preceded by sexual stimulation and were not associated with a pleasurable sensation. The discomfort disappeared after discontinuing zotepine. Zotepine-induced spontaneous ejaculation was, therefore, diagnosed. There are few reports of drug-related spontaneous ejaculation. Clinicians need to recognize the possibility of zotepine-related spontaneous ejaculation because sexual side effects have an impact on medical adherence.
Author information
Author/s: Wang, P-W (PW); Wang, S Y (SY); Huang, C-J (CJ);
Affiliation: Department of Psychiatry, Kaohsiung Kai-Suan Psychiatric Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Journal and publication information
Publication Type: Case Reports; Journal Article
Journal: International journal of clinical pharmacology and therapeutics (Int J Clin Pharmacol Ther), published in Germany. (Language: eng)
Reference: 2008-Nov; vol 46 (issue 11) : pp 571-3
Dates: Created 2008/11/12; Completed 2009/01/15;
PMID: 19000555, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Antipsychotic Agents (0) ; Dibenzothiepins (0) ; zotepine (26615-21-4) ; Haloperidol (52-86-8)Related articles
These are the most related articles currently in our database:
- Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol.
29 Nov 2001 - [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol]
30 Aug 1991 - Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol.
30 Dec 1991 - A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
30 Dec 1995 - Zotepine for schizophrenia.
16 Oct 2006 - [Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind study]
30 Aug 1991 - Low-dose zotepine in the maintenance treatment of schizophrenia.
30 Jan 1987 - Clinical experience with the neuroleptic zotepine--first results.
30 Jan 1987 - [Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses]
30 Dec 1992 - Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
30 Dec 1988
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.